Showing results (1511-1520 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|August 8, 2015
Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infectionKarolina Rembeck, Martin Lagging
Pharmacogenomics|August 8, 2015
SOST polymorphisms and response to alendronate treatment in postmenopausal Chinese women with osteoporosisPei-ran Zhou, Xiao-jie Xu, Zhen-lin Zhang, et al.
Pharmacogenomics|August 11, 2015
De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancerAdela Madrid-Paredes, Marisa Cañadas-Garre, Antonio Sánchez-Pozo, et al.
Pharmacogenomics|August 13, 2015
Serotonergic gene variation in substance use pharmacotherapy: a systematic reviewIsabelle E Bauer, David P Graham, Jair C Soares, et al.
Pharmacogenomics|August 13, 2015
Discussing the putative role of obesity-associated genes in the etiopathogenesis of eating disordersGuillermo Gervasini, Carmen Gamero-Villarroel
Pharmacogenomics|August 4, 2015
Molecular biomarkers in colorectal carcinomaElena Puerta-García, Marisa Cañadas-Garre, Miguel Ángel Calleja-Hernández
Pharmacogenomics|August 6, 2015
Evaluation of predictive CYP2C19 genotyping assays relative to measured phenotype in a South African cohortTyren M Dodgen, Britt I Drögemöller, Galen E B Wright, et al.
Pharmacogenomics|October 1, 2015
Evaluation of the use of clinical decision support and online resources for pharmacogenomics educationCarolyn R Rohrer Vitek, Wayne T Nicholson, Cloann Schultz, et al.
Pharmacogenomics|January 23, 2016
New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugsLucie Pouché, Jana Stojanova, Pierre Marquet, et al.
Pharmacogenomics|October 21, 2015
What role could organoids play in the personalization of cancer treatment?Hayley E Francies, Mathew J Garnett
Pageof 276